Please login to the form below
Healthcare terms - R
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - R
- Random samplings
- Randomisation
- Randomised trial
- Range
- Rate card
- Reach
- Readership
- Recall test
- Recession
- Reciprocal links
- Recognition tests
- Recruiting
- Recruitment status
- Reference group
- Reference pricing
- Registered trademark
- Regression analysis
- Reimbursement
- Reinforcement advertising
- Relationship marketing
- Relative advantage
- Relative market share
- Repositioning
- Reprint
- Research and development (R&D)
- Research proposal
- Respondent
- Respondent fatigue
- Response bias
- Response rate
- Responsiveness
- Return on equity (ROE)
- Return on investment (ROI)/Return on capital employed (ROCE)
- Return on sales enablement (ROSE)
- Risk analysis
- Risk-benefit analysis
- Routine response behaviour
- Royal Pharmaceutical Society of Great Britain (RPSGB)
- RSS
Featured jobs
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
-
Senior Medical Writer
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
-
Senior Copywriter
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer opens AI-enabled drug discovery center in UK
- The best in the UK healthcare system celebrated at QiC Diabetes awards 2019
- Merck wins CHMP recommendation for Ebola vaccine
- Roche scores another FDA approval for Xofluza
- CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal
- AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs
- A snapshot of Crescendo Biologics
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Quick links
Infographics
